CGIX

Cancer Genetics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Cancer Genetics Inc CGIX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.12 -1.87% 6.30 20:00:00
Open Price Low Price High Price Close Price Prev Close
6.16 5.7501 6.58 6.51 6.42
more quote information »

Recent News

Date Time Source Heading
2/26/202116:51EDGARRevised Proxy Soliciting Materials (definitive) (defr14a)
2/26/202116:47EDGARFiling of Certain Prospectuses and Communications in..
2/16/202117:00EDGARCurrent Report Filing (8-k)
2/16/202116:45GLOBECancer Genetics Announces Closing of $17.5 Million Common..
2/16/202106:38EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/16/202106:38EDGARNotice of Effectiveness (effect)
2/11/202106:08EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/11/202106:07EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202123:46SEEKCancer Genetics to raise $17.5M via stock offering
2/10/202123:00GLOBECancer Genetics Announces $17.5 Million Common Stock..
2/10/202111:35SEEKCancer Genetics more than doubles after merger terms update
2/09/202106:18EDGARStatement of Ownership (sc 13g)
2/09/202106:06EDGARNotice of Effectiveness (effect)
2/08/202117:21EDGARFiling of Certain Prospectuses and Communications in..
2/08/202116:56EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
2/08/202110:48EDGARRegistration Statement for Securities to Be Issued in..
2/03/202116:47EDGARStatement of Ownership (sc 13g)
2/03/202109:04EDGARSmall Company Offering and Sale of Securities Without..
2/01/202117:30EDGARSecurities Registration Statement (simplified Form) (s-3)
2/01/202117:16GLOBECancer Genetics Announces Closing of $10.0 Million Private..
1/28/202116:01GLOBECancer Genetics Announces $10.0 Million Private Placement..
1/28/202115:41EDGARFiling of Certain Prospectuses and Communications in..
1/08/202116:31EDGARFiling of Certain Prospectuses and Communications in..
1/08/202116:31EDGARCurrent Report Filing (8-k)
1/07/202116:05GLOBECancer Genetics to Present at the 2021 BioConnect Virtual..
1/07/202108:30EDGARFiling of Certain Prospectuses and Communications in..
12/03/202008:13EDGARCurrent Report Filing (8-k)
12/03/202008:13EDGARCurrent Report Filing (8-k)
12/03/202008:13EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/20/202017:27EDGARCurrent Report Filing (8-k)
11/12/202017:10EDGARFiling of Certain Prospectuses and Communications in..
11/12/202017:07EDGARCurrent Report Filing (8-k)
11/12/202016:25GLOBECancer Genetics Reports Third Quarter 2020 Financial Results
11/12/202016:17EDGARQuarterly Report (10-q)
11/09/202010:40EDGARStatement of Beneficial Ownership (sc 13d)
11/02/202016:00GLOBECancer Genetics, Inc. Announces Closing of Public Offering..
11/02/202006:04EDGARStatement of Ownership (sc 13g)
10/30/202009:08EDGARStatement of Ownership (sc 13g)
10/29/202017:25EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/29/202006:06EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
10/28/202021:55GLOBECancer Genetics, Inc. Increases Previously Announced Bought..
10/28/202017:53GLOBECancer Genetics, Inc. Announces $2.0 Million Bought Deal..
10/28/202017:26EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/19/202009:16EDGARCurrent Report Filing (8-k)
10/16/202011:39EDGARSecurities Registration: Business Combination (s-4)
9/30/202016:12EDGARCurrent Report Filing (8-k)
9/24/202009:11EDGARCurrent Report Filing (8-k)
9/15/202016:17EDGARCurrent Report Filing (8-k)
9/10/202008:00GLOBECancer Genetics Announces Participation at the 22nd Annual..
9/03/202008:01EDGARFiling of Certain Prospectuses and Communications in..
See more news about this stock »


Your Recent History
NASDAQ
CGIX
Cancer Gen..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.